Pharsight

SANDOZ AG PATENTS FACING OPPOSITIONS

Top patents of SANDOZ AG facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3434265B1 07 Jul, 2021 Pharmaceutical Composition Containing Rifaximin Alpha & Delta Mar, 2037 3
EP3294270B1 12 Sep, 2018 Pharmaceutical Composition Containing Rifaximin Alpha&Delta Mar, 2037 2
EP3536311B1 22 Dec, 2021 Storage Stable Composition Comprising Rifaximin Alpha Mar, 2037 1
EP3390358B1 23 Sep, 2020 Crystalline Eravacycline Bis-Hydrochloride Jan, 2037 1
EP2977372B1 08 May, 2019 Polymorphs Of Febuxostat Jun, 2031 1
EP3003277B1 20 Feb, 2019 Process For The Preparation Of A Pharmaceutical Composition Comprising Rivaroxaban May, 2034 1